Shire Proposes to Expand Specialist Gastrointestinal Portfolio
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that a Luxembourg incorporated wholly-owned subsidiary of Shire plc will launch a voluntary public takeover offer for all the shares in Movetis NV, the Belgium-based European specialty gastrointestinal (GI) company.
Original Source of Shire Proposes to Expand Specialist Gastrointestinal Portfolio
